DOI: https://dx.doi.org/10.18565/urology.2022.5.5-14
М.И. Коган, Р.С. Исмаилов, С.С. Тодоров, Ю.Л. Набока, И.А. Гудима
1) Кафедра урологии и репродуктивного здоровья человека (с курсом детской урологии–андрологии) ФГБОУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения РФ, Ростов-на-Дону, Россия; 2) Кафедра микробиологии и вирусологии № 1 ФГБОУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения РФ, Ростов-на-Дону, Россия; 3) Морфологический отдел Клиники РостГМУ, кафедра патологической анатомии ФГБОУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения РФ, Ростов-на-Дону, Россия
1. Kogan M.I., Naboka Yu.L., Todorov S.S., Ismailov R.S. Experimental evaluation of inflammatory process in the prostate caused by transurethral transmission of uropathogen in low counts. Urologiia. 2019;5:14–21. Russian ( Коган М.И., Набока Ю.Л., Тодоров С.С., Исмаилов Р.С. Экспериментальная оценка течения воспалительного процесса в простате при ее трансуретральном инфицировании низким титром уропатогена. Урология. 2019;5:14–21).Doi: 10.18565/urology.2019.5.14–21. 2. Kogan M.I., Naboka Yu.L., Todorov S.S., Ismailov R.S. Comparative evaluation of the development and occurence of the inflammatory process in prostate under its transusretral infection using the low counts of causative and debatable microorganism strains. Experimental and clinical urology 2019; (3):40-48. Russian (Коган М.И., Набока Ю.Л., Тодоров С.С., Исмаилов Р.С. Сравнительная оценка развития и течения воспалительного процесса в простате при трансуретральном инфицировании с использованием каузативного и дебатируемых штаммов микроорганизмов в низких титрах. Экспериментальная и клиническая урология. 2019;3:40-48). Doi: 10.29188/2222-8543-2019-11-3-40-48. 3. Ismailov R.S., Naboka Y.L., Todorov S.S., Kogan M.I. Are bacteriological and pathomorphological signs of bacterial prostatitis related between? (An experimental study) Urologiia. 2020;6:44–52. Russian (Исмаилов Р.С., Набока Ю.Л., Тодоров С.С., Коган М.И. Связаны ли между собой бактериологические и патоморфологические признаки бактериального простатита? (экспериментальное исследование). Урология. 2020;6:44–52). Doi: 10.18565/urology.2020.6.44-51. 4. Dennis L.K., Lynch C.F., Torner J.C. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002;60(1):78–83. Doi: 10.1016/s0090-4295(02)01637-0. 5. Jiang J., Li J., Yunxia Z., Zhu H., Liu J., Pumill C. The role of prostatitis in prostate cancer: meta-analysis. PLoS One. 2013;8(12):e85179. Doi: 10.1371/journal.pone.0085179. 6. Schetter A.J., Heegaard N.H., Harris C.C. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 2010;31(1):37–49. Doi: 10.1093/carcin/bgp272. 7. Lonkar P., Dedon P.C. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer. 2011;128(9):1999–2009. Doi: 10.1002/ijc.25815. 8. Pan JS, Hong MZ, Ren JL. Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol. 2009;15(14):1702–1707. Doi: 10.3748/wjg.15.1702. 9. Shen H.M., Tergaonkar V. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis. 2009;14(4):348–363. Doi: 10.1007/s10495-009-0315-0. 10. Pascal L.E., Wang Y., Zhong M., Wang D., Chakka A.B., Yang Z., Li F., Song Q., Rigatti L.H., Chaparala S., Chandran U., Parwani A.V., Wang Z. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Neoplasia. 2018;20(4):351–363. Doi: 10.1016/j.neo.2018.01.011. 11. Bollrath J., Greten F.R. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep. 2009;10(12):1314–1349. Doi: 10.1038/embor.2009.243. 12. Fisher G., Yang Z.H., Kudahetti S., Møller H., Scardino P., Cuzick J., Berney D.M. Transatlantic Prostate Group. Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort. Br J Cancer. 2013 Feb 5;108(2):271–277. Doi: 10.1038/bjc.2012.598. Epub 2013 Jan 17. PMID: 23329234; PMCID: PMC3566811. 13. Kudryavtsev GY, Kudryavtseva LV, Mikhaleva LM, Solovieva NA, Babichenko II. Immunohistochemical study of Ki-67, p53 and Notch1 expressions in prostate cancer of different grades. Arkh Patol. 2020;82(5):42–49. Russian. Doi: 10.17116/patol20208205142. 14. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of Animals used for Scientific purposes. OJ L 2010;276: 33–79. 15. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS No.123). Appendix A «Guidelines for the maintenance and care of animals». Adopted: Strasbourg, 18.03.1986, entry in force: 01.01.1991. URL: https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=090000168007a67b 16. Mahler M., Berard M., Feinstein R., Gallagher A., Illgen-Wilcke B., Pritchett-Corning K., Raspa M. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim 2014;48(3); 178–192. Doi: 10.1177/0023677213516312 17. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010;8(6): e1000412. Doi: 10.1371/journal.pbio.1000412. 18. Nickel J.C., Olson M.E., Barabas A., Benediktsson H., Dasgupta M.K., Costerton J.W. Pathogenesis of Chronic Bacterial Prostatitis in an animal model. British J of Urol. 1990;66(6): 47–54. Doi: 10.1111/j.1464-410X.1990.tb14864.x 19. Petrescu A., Mârzan L., Codreanu O., Niculescu L. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate carcinoma. Rom J Morphol Embryol. 2006;47:143–146. 20. Madani S.H., Ameli S., Khazaei S., Kanani M., Izadi B. Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer. Indian J Pathol Microbiol. 2011;54:688–691. 21. Kaplan L., Lee C., Schaeffer A.J. Effect of castration on experimental bacterial prostatitis in rats. Prostate. 1983;4(6):625–630. Doi: 10.1002/pros.2990040608. 22. Seo S.I., Lee S.J., Kim J.C., Choi Y.J., S.W .S.W., Hwang T.K., Cho Y.H. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003;10(9):485–491. Doi: 10.1046/j.1442-2042.2003.00666.x. PMID: 12941127.. 23. Elkahwaji E., Zhong W., Janda L.M., Bjorling D.E., Bushman W. Chronic prostatic infection and inflammation induce reactive dysplasia and neoplasia in mice. J Urol 2006;175 (Suppl):258. 24. Elkahwaji J.E., Ott C.J., Janda L.M., Hopkins W.J. Mouse model for acute bacterial prostatitis in genetically distinct inbred strains. Urology. 2005;66(4):883–887. Doi: 10.1016/j.urology.2005.04.013. 25. Verma R, Gupta V, Singh J, Verma M, Gupta G, Gupta S, Sen R, Ralli M. Significance of p53 and ki-67 expression in prostate cancer. Urol Ann. 2015;7(4):488–493. Doi: 10.4103/0974-7796.158507. 26. Jiang T., Jiang H., Song X.S., Li X.C., Li Q.L. P53 expression and its clinical significance in prostatic carcinoma. Zhonghua Nan Ke Xue. 2005;11:448–451:454. 27. Olivier M., Hainaut P., Børresen-Dale A.L. (2007). Prognostic and Predictive Value of TP53 Mutations in Human Cancer. In: Hainaut, P., Wiman, K.G. (eds) 25 Years of p53 Research. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-2922-6_14 28. Bourdon J.C. p53 and its isoforms in cancer. Br J Cancer. 2007;97(3):277–282. Doi: 10.1038/sj.bjc.6603886. 29. Wang Y., Abenojar E.C., Wang J., de Leon A.C., Tavri S., Wang X., Gopalakrishnan R., Walker E., MacLennan G.T., Giles A., Czarnota G.J., Basilion J.P., Exner A.A. Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit. Prostate. 2022;82(6):695–705. Doi: 10.1002/pros.24314.
А в т о р д л я с в я з и: Р. С. Исмаилов – к.м.н., ассистент кафедры урологии и репродуктивного здоровья человека (с курсом детской урологии-андрологии) ФГБОУ ВО РостГМУ Минздрава России, Ростов-на-Дону, Россия; е-mail: dr.ruslan.ismailov@gmail.com